Chronic pain is one of the most complex and costly conditions in modern healthcare, affecting more than 100 million Americans and generating over $635 billion in annual societal burden. For clinicians practicing at the intersection of functional neurology and pain management, the demand for evidence-based, non-pharmacologic interventions has never been greater. Prescription immersive therapeutics represents a new and rigorously validated category of medicine, one that harnesses the neurological power of virtual reality to deliver scalable, home-based cognitive behavioral therapy for chronic low back pain.

This course equips advanced clinicians with the scientific and clinical foundation to understand, evaluate, and integrate prescription VR into their conceptual framework for pain care. Through the lens of the biopsychosocial model, learners explore how immersive therapeutics addresses the multidimensional nature of chronic pain, combining diaphragmatic breathing, mindfulness, pain neuroscience education, and CBT-based skill acquisition within a single FDA-authorized platform. The clinical evidence base is substantial: three randomized controlled trials, including two sham-controlled, double-blinded studies enrolling over 1,200 patients, demonstrate statistically significant and clinically meaningful reductions in pain intensity and pain interference, with durability extending to 24 months post-treatment.

This course is designed for licensed clinicians in functional neurology, rehabilitation, and integrative pain management who are looking to expand their understanding of emerging digital therapeutics and their place within evidence-based, multimodal pain care. Whether your practice involves direct prescribing or referral coordination, this course provides the clinical intelligence to evaluate prescription VR as a credible adjunct in complex pain cases.